D-1087-2015 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Horsham, PA

FDA drug recall D-1087-2015 was initiated by Teva Pharmaceuticals USA on May 7, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing. The recall status is terminated (terminated Nov 15, 2016). Affected quantity: 233,364 Inhalers.

Recall details

Product Type
Drugs
Report Date
Jun 3, 2015
Initiation Date
May 7, 2015
Termination Date
Nov 15, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
233,364 Inhalers

Product description

QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For Oral Inhalation with QVAR Actuator Only, 120 metered inhalations, Rx Only, Mktd by Teva Respiratory, LLC., Horsham, PA. mfd by 3M Drug Delivery Systems, Northridge, CA, NDC 59310-0202-12

Reason for recall

Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.

Distribution pattern

Nationwide and Peurto Rico

Code information

Lot #s:130449, 130450; Exp. Date: 12/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1087-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1087-2015. Report a data issue: hello@regdatalab.com.